Infographics

31. The Importance Of Final Dosage Form For Clinical Trial Material 6/15/2020

    In Q4, 2019 ISR asked 100 outsourcers of clinical manufacturing how important it is for the clinical trial material, or IMP, to be in its final dosage form. 44% of respondents said it is very-extremely important for the IMP to be in the final dosage form. Another 47% said it is important. 

32. Comfort Level With Data Sharing 3/13/2020

    In Q4, 2019, ISR asked 676 outsourcers of manufacturing activities and services about their comfort level regarding data sharing between sponsors and service providers. The graph below shows how each of the data-sharing scenarios panned out, with sponsors being most comfortable with data sharing between their CMO and their own manufacturing department.

33. 3 Year Rolling Average – Small Molecule API Customer Loyalty 1/14/2020

    In Q4, 2019, ISR asked sponsors who outsource small molecule API to gain insight into customer loyalty. CMO loyalty is computed as an index that consists of overall satisfaction, willingness to recommend, and the likelihood of using the contract manufacturer again. The data below show companies with ten or more responses from recent users for each of the past three years and an industry average derived from all CMOs included in the research; their loyalty component scores are aggregated, averaged and then weighted based on the number of customer interactions.

34. The Most Popular Oral Dosage Form 12/12/2019

    In Q2, 2019, ISR asked outsourcers of oral dose manufacturing several questions about the different oral dosage forms in their company’s portfolio. Below are the results for the most popular oral dosage form among respondents, the tablet.

35. Clinical Logistics Service Provider Use by Category 11/11/2019

    In Q3, 2019, ISR asked outsourcers of clinical logistics about the types of service providers they use and prefer for clinical logistics. The data show the majority of outsourcers use integrated clinical trial service providers (79%), specialty couriers (71%) and package delivery companies’ healthcare offering (63%).

36. Top Five Oral Dosage Forms By Portfolio Composition 9/12/2019

    The top five oral dosage forms account for more than half of products in oral dose portfolios and are: tablets, capsules, controlled release tablets, controlled release capsules, and immediate release tablets.

37. Customer Loyalty In Small Molecule Drug Substance Manufacturing 4/15/2019

    In Q4, 2018, ISR surveyed 134 sponsors who outsource drug substance manufacturing for small molecule compounds to gain insight into their CMO loyalty. ISR computes customer loyalty as an index that consists of overall satisfaction, willingness to recommend, and likelihood to use the CMO again.

38. Approaches To CMC Involvement Across Drug Development 9/18/2018

    In Q42017, ISR interviewed fifteen tenured CMC professionals at top 50 Pharma companies to learn when during the drug development cycle CMC has its greatest involvement and influence. 

39. Preferred Pharmaceutical Service Providers Use 11/16/2017

    This infographic provides an overview of preferred provider arrangements with research, software, and manufacturing organizations by presenting data on preferred provider use, quantity, and selection drivers.

40. Outsourcers' CMO Preferences

    In Q4, 2019, ISR asked 676 buyers of outsourced manufacturing services about which types of CMOs their organization prefers, large, global CMOs with broad capabilities or Small, niche CMOs with highly specialized capabilities. Respondents’ preference leans towards the big guys. 44% agree-strongly agree that their organization prefers large, global CMOs as compared to 28% who indicate their organization prefers smaller, niche CMOs with specialized capabilities.